Starling Oncology TOI
TOI
$6.20 +0.01 (+0.16%)
At close: Aug 11, 2026 · 4:00 PM EDT

Oncology Institute, Inc. (TOI) Times Interest Earned (2020 - 2026)

Oncology Institute's (TOI) quarterly Times Interest Earned came in at -$2.92 in Q1 2026, down 64.29% YoY from -$8.19 in Q1 2025, and down 248.74% on a QoQ basis from -$0.84 in Q4 2025.

Oncology Institute, Inc. (TOI) Times Interest Earned (2020 - 2026) Analysis & Trends

Oncology Institute (TOI) has 7 years of Times Interest Earned data on file, last reported at -$2.92 in Q1 2026.

  • Quarterly Times Interest Earned fell 64.29% year-over-year to -$2.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.79 (up 56.65% YoY) and the FY2025 annual result came in at -$0.48, up 49.74% from the prior year.
  • Times Interest Earned slipped to -$2.92 in Q1 2026, from -$0.84 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $46.33 in Q4 2023 to a low of -$11.92 in Q1 2023.
  • A 5-year average of -$0.94 and a median of -$3.39 in 2023 frame the typical range for Times Interest Earned.
  • The widest YoY moves for Times Interest Earned: up 1052.81% in 2023, down 587.73% in 2023.
  • Tracing TOI's Times Interest Earned over 5 years: stood at -$4.86 in 2022, then surged by 1052.81% to $46.33 in 2023, then tumbled by 111.81% to -$5.47 in 2024, then jumped by 84.67% to -$0.84 in 2025, then slumped by 248.74% to -$2.92 in 2026.
  • The last three Times Interest Earned figures came in at -$2.92 (Q1 2026), -$0.84 (Q4 2025), and -$1.02 (Q3 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.16
Mar 31, 2026 -2.92
Dec 31, 2025 -0.84
Sep 30, 2025 -1.02
Jun 30, 2025 -2.12
Mar 31, 2025 -1.78
Dec 31, 2024 -5.47
Sep 30, 2024 -4.90
Jun 30, 2024 -5.79
Mar 31, 2024 -3.59
Dec 31, 2023 46.33
Sep 30, 2023 -3.39
Jun 30, 2023 -5.11
Mar 31, 2023 -11.92
Dec 31, 2022 -4.86
Sep 30, 2022 -0.92
Jun 30, 2022 -0.74
Mar 31, 2022 -7.00
Dec 31, 2021 -68.74
Jun 30, 2021 -13.78